deltatrials
Unknown NA NCT01974297

Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid

Comparison of the Efficacy and AtorVastatin 20mg mOnotherapy Versus Combination Atorvastatin/Fenofibric Acid 10/135mg in the Mixed hyperlipiDemia Who Were Not at Lipid gOals With Atorvastatin 10mg Monotherapy.

Sponsor: Sang Hak Lee

Conditions Mixed Hyperlipidemia
Interventions Atorvastatin 10mg, fenofibric acid 135mg atorvastatin 20mg
Updated 6 times since 2017 Last updated: Oct 31, 2013 Started: Jul 31, 2013 Primary completion: Jun 30, 2014 Completion: Jul 31, 2014

This NA trial investigates Mixed Hyperlipidemia and is currently ongoing. Sang Hak Lee leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown NA

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown NA

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status NA

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Unknown Status NA

    First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sang Hak Lee
Data source: Yonsei University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Seoul, South Korea